The favourable actions of CD19+ PD‐L1+ B cells in humoural B‐cell homeostasis and in the control of autoimmune diseases were further supported by the demonstration that these B cells are resistant to αCD20 B‐cell depletion54 and that MC patients also benefit from αCD20 treatment.76 Here, CD19 is linked to autoimmune disease.